Bristol-Myers Squibb

YTD

ALL

Trade Bristol-Myers Squibb 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BMY

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies.

CEO

Christopher S. Boerner

CEOChristopher S. Boerner

Employees

32,500

Employees32,500

Headquarters

Princeton, New Jersey

HeadquartersPrinceton, New Jersey

Founded

1933

Founded1933

Employees

32,500

Employees32,500

BMY Key Statistics

Market cap

122.21B

Market cap122.21B

Price-Earnings ratio

17.56

Price-Earnings ratio17.56

Dividend yield

4.10%

Dividend yield4.10%

Average volume

13.87M

Average volume13.87M

High today

$60.66

High today$60.66

Low today

$59.45

Low today$59.45

Open price

$60.35

Open price$60.35

Volume

2.39M

Volume2.39M

52 Week high

$63.33

52 Week high$63.33

52 Week low

$42.52

52 Week low$42.52

Stock Snapshot

The current Bristol-Myers Squibb(BMY) stock price is $60.01, with a market capitalization of 122.21B. The stock trades at a price-to-earnings (P/E) ratio of 17.56 and offers a dividend yield of 4.1%.

During the trading session on 2026-03-06, Bristol-Myers Squibb(BMY) shares reached a daily high of $60.66 and a low of $59.45. At a current price of $60.01, the stock is +1.0% higher than the low and still -1.1% under the high.

Trading volume for Bristol-Myers Squibb(BMY) stock has reached 2.39M, versus its average volume of 13.87M.

Over the past 52 weeks, Bristol-Myers Squibb(BMY) stock has traded between a high of $63.33 and a low of $42.52.

BMY News

Simply Wall St 2d

Assessing Bristol Myers Squibb Valuation After Recent Share Price Momentum And 2024 Results

Advertisement Why Bristol-Myers Squibb (BMY) Is On Investors’ Radar Today Bristol-Myers Squibb (BMY) has drawn fresh attention after recent trading left the s...

Simply Wall St 6d

Bristol-Myers Squibb Cancer Advances Test Valuation Gap For Investors

Bristol-Myers Squibb (NYSE:BMY) and SystImmune report highly positive Phase 3 interim results for izalontamab brengitecan in advanced triple-negative breast can...

Analyst ratings

59%

of 32 ratings

Buy

37.5%

Hold

59.4%

Sell

3.1%

People also own

Based on the portfolios of people who own BMY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.